Luminopsins integrate opto- and chemogenetics by using physical and biological light sources for opsin activation

Significance Although conventional optogenetics utilizing microbial photosensitive channels or pumps to control activity of neurons has enabled great progress in neuroscience, reliance on delivery of light by optic fibers implanted into the brain imposes certain logistical burdens and thus limits application of optogenetics. To expand their utility, we fused optogenetic probes with luciferase that emits biological light in the presence of a substrate and showed that the activity of neurons in vitro, ex vivo, and in vivo could be controlled by biological light in addition to physical light. Such fusion proteins, termed luminopsins, could prove invaluable for experimental and clinical neuroscience. Luminopsins are fusion proteins of luciferase and opsin that allow interrogation of neuronal circuits at different temporal and spatial resolutions by choosing either extrinsic physical or intrinsic biological light for its activation. Building on previous development of fusions of wild-type Gaussia luciferase with channelrhodopsin, here we expanded the utility of luminopsins by fusing bright Gaussia luciferase variants with either channelrhodopsin to excite neurons (luminescent opsin, LMO) or a proton pump to inhibit neurons (inhibitory LMO, iLMO). These improved LMOs could reliably activate or silence neurons in vitro and in vivo. Expression of the improved LMO in hippocampal circuits not only enabled mapping of synaptic activation of CA1 neurons with fine spatiotemporal resolution but also could drive rhythmic circuit excitation over a large spatiotemporal scale. Furthermore, virus-mediated expression of either LMO or iLMO in the substantia nigra in vivo produced not only the expected bidirectional control of single unit activity but also opposing effects on circling behavior in response to systemic injection of a luciferase substrate. Thus, although preserving the ability to be activated by external light sources, LMOs expand the use of optogenetics by making the same opsins accessible to noninvasive, chemogenetic control, thereby allowing the same probe to manipulate neuronal activity over a range of spatial and temporal scales.

[1]  A. Grace,et al.  Morphology and electrophysiological properties of immunocytochemically identified rat dopamine neurons recorded in vitro , 1989, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[2]  W. C. Hall,et al.  High-speed mapping of synaptic connectivity using photostimulation in Channelrhodopsin-2 transgenic mice , 2007, Proceedings of the National Academy of Sciences.

[3]  B. Roth,et al.  DREADD: A Chemogenetic GPCR Signaling Platform , 2014, The international journal of neuropsychopharmacology.

[4]  David Fan,et al.  Mechanisms of Action Selection and Timing in Substantia Nigra Neurons , 2012, The Journal of Neuroscience.

[5]  Robert E. Gross,et al.  Inhibitory luminopsins: genetically-encoded bioluminescent opsins for versatile, scalable, and hardware-independent optogenetic inhibition , 2015, Scientific Reports.

[6]  Karthish Manthiram,et al.  Multiply mutated Gaussia luciferases provide prolonged and intense bioluminescence. , 2009, Biochemical and biophysical research communications.

[7]  L. Looger,et al.  Chemical and Genetic Engineering of Selective Ion Channel–Ligand Interactions , 2011, Science.

[8]  David J. Anderson,et al.  Reversible Silencing of Neuronal Excitability in Behaving Mice by a Genetically Targeted, Ivermectin-Gated Cl− Channel , 2007, Neuron.

[9]  Sung Bae Kim,et al.  Superluminescent variants of marine luciferases for bioassays. , 2011, Analytical chemistry.

[10]  K. Deisseroth,et al.  Red-shifted optogenetic excitation: a tool for fast neural control derived from Volvox carteri , 2008, Nature Neuroscience.

[11]  Takeharu Nagai,et al.  Luminescent proteins for high-speed single-cell and whole-body imaging , 2012, Nature Communications.

[12]  Lief E. Fenno,et al.  The development and application of optogenetics. , 2011, Annual review of neuroscience.

[13]  JM Tepper,et al.  GABAA receptor-mediated inhibition of rat substantia nigra dopaminergic neurons by pars reticulata projection neurons , 1995, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[14]  Michael A. Henninger,et al.  High-Performance Genetically Targetable Optical Neural Silencing via Light-Driven Proton Pumps , 2010 .

[15]  Jessica A. Cardin,et al.  Noninvasive optical inhibition with a red-shifted microbial rhodopsin , 2014, Nature Neuroscience.

[16]  R. Weissleder,et al.  Codon-optimized Gaussia luciferase cDNA for mammalian gene expression in culture and in vivo. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[17]  Benjamin R. Arenkiel,et al.  Transient activation of specific neurons in mice by selective expression of the capsaicin receptor , 2012, Nature Communications.

[18]  T. K. Christopoulos,et al.  Recombinant Gaussia luciferase. Overexpression, purification, and analytical application of a bioluminescent reporter for DNA hybridization. , 2002, Analytical chemistry.

[19]  Brock F. Binkowski,et al.  Engineered Luciferase Reporter from a Deep Sea Shrimp Utilizing a Novel Imidazopyrazinone Substrate , 2012, ACS chemical biology.

[20]  B. Tannous,et al.  Directed molecular evolution reveals Gaussia luciferase variants with enhanced light output stability. , 2013, Analytical chemistry.

[21]  Xi-Ping Huang,et al.  A New DREADD Facilitates the Multiplexed Chemogenetic Interrogation of Behavior , 2015, Neuron.

[22]  George J. Augustine,et al.  Light-Emitting Channelrhodopsins for Combined Optogenetic and Chemical-Genetic Control of Neurons , 2013, PloS one.

[23]  B. Roth,et al.  Chemogenetic tools to interrogate brain functions. , 2014, Annual review of neuroscience.

[24]  Joseph W. Barter,et al.  The role of the substantia nigra in posture control , 2014, The European journal of neuroscience.

[25]  D. Kleinfeld,et al.  ReaChR: A red-shifted variant of channelrhodopsin enables deep transcranial optogenetic excitation , 2013, Nature Neuroscience.

[26]  G. Collingridge,et al.  Evidence for the participation of nigrotectal γ-aminobutyrate-containing neurones in striatal and nigral-derived circling in the rat , 1982, Neuroscience.

[27]  Henry H. Yin,et al.  Bidirectional Modulation of Substantia Nigra Activity by Motivational State , 2013, PloS one.

[28]  Alnawaz Rehemtulla,et al.  NanoLuc Reporter for Dual Luciferase Imaging in Living Animals , 2013, Molecular imaging.

[29]  S. Greenfield,et al.  Topographic heterogeneity of substantia nigra neurons: Diversity in intrinsic membrane properties and synaptic inputs , 1993, Neuroscience.

[30]  M. Moline,et al.  Bioluminescence in the sea. , 2010, Annual review of marine science.

[31]  B. Roth,et al.  Evolving the lock to fit the key to create a family of G protein-coupled receptors potently activated by an inert ligand , 2007, Proceedings of the National Academy of Sciences.

[32]  K. Prasadan,et al.  Rapid and simplified purification of recombinant adeno-associated virus. , 2012, Journal of virological methods.

[33]  Oliver P. Ernst,et al.  Photoactivation of Channelrhodopsin* , 2008, Journal of Biological Chemistry.

[34]  A. Grace,et al.  Paradoxical GABA excitation of nigral dopaminergic cells: indirect mediation through reticulata inhibitory neurons. , 1979, European journal of pharmacology.

[35]  E. Callaway,et al.  A Genetic Method for Selective and Quickly Reversible Silencing of Mammalian Neurons , 2002, The Journal of Neuroscience.

[36]  George J Augustine,et al.  Non-invasive activation of optogenetic actuators , 2014, Photonics West - Biomedical Optics.

[37]  Karl Deisseroth,et al.  Next-generation transgenic mice for optogenetic analysis of neural circuits , 2013, Front. Neural Circuits.

[38]  Sanjiv Sam Gambhir,et al.  Red-shifted Renilla reniformis luciferase variants for imaging in living subjects , 2007, Nature Methods.

[39]  M. Kawato,et al.  Ca2+ Requirements for Cerebellar Long-Term Synaptic Depression: Role for a Postsynaptic Leaky Integrator , 2007, Neuron.

[40]  Takeharu Nagai,et al.  Expanded palette of Nano-lanterns for real-time multicolor luminescence imaging , 2015, Proceedings of the National Academy of Sciences.

[41]  H. Ahn,et al.  Can Atypical Antipsychotic Augmentation Reduce Subsequent Treatment Failure More Effectively Among Depressed Patients with a Higher Degree of Treatment Resistance? A Meta-Analysis of Randomized Controlled Trials , 2015, The international journal of neuropsychopharmacology.

[42]  N. Cozzarelli PNAS Early Edition. , 2000, Proceedings of the National Academy of Sciences of the United States of America.